A 26-WEEK STUDY OF EFFICACY AND SAFETY OF DELAYED-RELEASE PREDNISONE IN NEWLY DIAGNOSED CASES OF GIANT CELL ARTERITIS: AN INTERIM ANALYSIS

被引：0
|
作者：
Raine, Charles [1 ]
Maw, Win [1 ]
Williams, Mark [1 ]
Gayford, Dawn [1 ]
Mapplebeck, Sarah [1 ]
Mackerness, Craig [1 ]
Dasgupta, Bhaskar [1 ]
机构：
[1] Southend Univ Hosp NHS Fdn Trust, Dept Rheumatol, Westcliff On Sea, Essex, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
TEMPORAL ARTERITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页码：7 / 8
页数：4
相关论文
共 50 条
  • [1] A 26-WEEK STUDY OF EFFICACY AND SAFETY OF DELAYED-RELEASE PREDNISONE IN NEWLY-DIAGNOSED CASES OF GIANT CELL ARTERITIS: AN INTERIM ANALYSIS
    Raine, C.
    Maw, W. W.
    Williams, M.
    Gayford, D.
    Mapplebeck, S.
    Borg, F. A.
    Mackerness, C.
    Hirst, D.
    Dasgupta, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 551 - 551
  • [2] A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis
    Raine, Charles
    Stapleton, Philip P.
    Merinopoulos, Dimos
    Maw, Win Win
    Achilleos, Katerina
    Gayford, Dawn
    Mapplebeck, Sarah
    Mackerness, Craig
    Schofield, Paul
    Dasgupta, Bhaskar
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (01) : 285 - 291
  • [3] PHASE II STUDY OF THE SAFETY AND EFFICACY OF INFLIXIMAB IN GIANT CELL ARTERITIS (GCA): 22 WEEK INTERIM ANALYSIS
    Hoffman, G. S.
    Cid, M. C.
    Weyand, C. M.
    Stone, J. H.
    Rendt, K. E.
    Salvarani, C.
    Merkel, P. A.
    Xu, W.
    Visvanathan, S.
    Rahman, M. U.
    RHEUMATOLOGY, 2005, 44 : 18 - 19
  • [4] Phase II study of the safety and efficacy of infliximab in giant cell arteritis (GCA): 22 week interim analysis.
    Hoffman, GS
    Cid, MC
    Weyand, CM
    Stone, JH
    Rendt, KE
    Salvarani, C
    Merkel, PA
    Xu, WC
    Visvanathan, S
    Rahman, MU
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S271 - S271
  • [5] Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Meltzer, Leslie
    Kurukulasuriya, Nuwan C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 57 - 66
  • [6] A Proof of Concept Study to Assess the Efficacy of Tocilizumab in Combination with Ultra-Short Glucocorticoid Administration to Treat Newly Diagnosed Giant Cell Arteritis - a 24 Week Analysis
    Christ, Lisa
    Seitz, Luca
    Buetikofer, Lukas
    Scholz, Godehard
    Sarbu, Adela-Cristina
    Amsler, Jennifer
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM
    Everage, Nicholas J.
    Prada, Claudia
    Liu, Shifang
    Balashov, Konstantin
    Macdonell, Richard
    Windsheimer, Jorg
    Giles, Kathryn
    NEUROLOGY, 2017, 88
  • [8] Safety and efficacy of delayed-release dimethyl fumarate in multiple sclerosis patients treated in routine medical practice: interim analysis of ESTEEM
    Everage, N. J.
    Jones, C. C.
    Das, R.
    Hanna, J.
    Liu, S.
    Balashov, K.
    Macdonell, R.
    Windsheimer, J.
    Giles, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 715 - 716
  • [9] Long-term efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 95 - 96
  • [10] Long-term efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 27 - 27
12345